López-Valverde Nansi, Rueda José Antonio Blanco
Department of Surgery, University of Salamanca, 37008 Salamanca, Spain.
Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.
Healthcare (Basel). 2024 Sep 14;12(18):1844. doi: 10.3390/healthcare12181844.
Periodontitis is a chronic infectious-inflammatory pathology, with a high prevalence, which destroys the dental support and, if left untreated, leads to tooth loss. It is associated with other pathologies, particularly diabetes mellitus.
Our objective was to conduct a review of systematic reviews with meta-analyses to determine the evidence for periodontal treatment on periodontitis and diabetes. Second, we assessed the risk of bias and methodological quality using the AMSTAR-2 and ROBIS tools.
We performed bibliographic searches in PubMed/Medline, Embase, Cochrane Central, Dentistry & Oral Sciences Source databases and in the Web of Science (WOS) scientific information service to identify systematic reviews with meta-analyses from the last five years.
Eighteen studies that met the inclusion criteria and evaluated 16,247 subjects were included. The most studied parameters were probing pocket depth, clinical attachment level, bleeding on probing and the glycated hemoglobin. Most of the included meta-analyses evaluated adult patients with periodontitis and type 2 diabetes mellitus (T2DM). Most of the meta-analyses considered and assessed by AMSTAR-2 showed significant methodological errors. The risk of bias was the domain with the worst assessment with the ROBIS tool.
Despite the weaknesses of the included meta-analyses in terms of methodological quality and the risk of bias, periodontal treatment and DM treatment appear to contribute to improved clinical outcomes in a bidirectional manner between periodontitis and DM.
牙周炎是一种慢性感染性炎症性疾病,患病率高,会破坏牙齿支持组织,若不治疗会导致牙齿脱落。它与其他疾病相关,尤其是糖尿病。
我们的目的是对进行了荟萃分析的系统评价进行综述,以确定牙周治疗对牙周炎和糖尿病的证据。其次,我们使用AMSTAR-2和ROBIS工具评估偏倚风险和方法学质量。
我们在PubMed/Medline、Embase、Cochrane Central、牙科学与口腔科学源数据库以及科学信息服务Web of Science(WOS)中进行文献检索,以识别过去五年中进行了荟萃分析的系统评价。
纳入了18项符合纳入标准并评估了16247名受试者的研究。研究最多的参数是探诊深度、临床附着水平、探诊出血和糖化血红蛋白。大多数纳入的荟萃分析评估了患有牙周炎和2型糖尿病(T2DM)的成年患者。大多数由AMSTAR-2考虑和评估的荟萃分析显示出重大的方法学错误。偏倚风险是ROBIS工具评估最差的领域。
尽管纳入的荟萃分析在方法学质量和偏倚风险方面存在不足,但牙周治疗和糖尿病治疗似乎以双向方式对牙周炎和糖尿病之间改善临床结局有帮助。